Biotech financing update June to August 2019

Chris Molloy on Mike Hoare, the RedX-Skye deal, Stablepharma’s fridge-free vaccine, MHRA quarterly numbers, ministerial responsibilities for UK life sciences and human biology-based models

Mironid raises $46 million in Series B financing to advance clinical development of its treatment for rare kidney disease

The advantages to building a business in the UK's biotech clusters

Chris Molloy on new pension scale-up fund news, member news from Touchlight, the major GSK investment in Cambridge, a valuable collaboration for Relation and BIA's parliamentary engagement

Find out more about a free, independent review of R&D tax claims for BIA members.

Up to $110 million upfront and success-based milestones collaboration will generate large-scale human cellular perturbation datasets to advance understanding of disease biology.